SCHEDULE 13G/A: Janus Henderson Group Discloses 8.8% Stake in Beauty Health Company

Janus Henderson Group PLC and its subsidiary, Janus Henderson Contrarian Fund, have filed an amended Schedule 13G, revealing a combined beneficial ownership of 8.8% in The Beauty Health Company's common stock.

Summary

• Janus Henderson Group PLC, a Jersey-based parent holding company and investment adviser, reported beneficial ownership of 11,105,656 shares of The Beauty Health Company's common stock.
• This aggregate amount represents 8.8% of the class of securities, with shared voting and dispositive power over all reported shares.
• Janus Henderson Contrarian Fund, a Massachusetts-based investment company and indirect subsidiary of Janus Henderson Group PLC, reported beneficial ownership of 11,020,425 shares, also representing 8.8% of the class.
• The filing is an Amendment No. 5 to a Schedule 13G, indicating a change in previously reported beneficial ownership.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a standard beneficial ownership disclosure (Schedule 13G) and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook. It is a factual report of an institutional investor's stake.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which can influence market perception and liquidity.
• Management: Awareness of a large institutional holder's stake, though the filing states the holding is not for control purposes.

Key Dates

Keywords

Janus Henderson Group PLC, The Beauty Health Company, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Investment Company, SEC Filing, Shareholding, Institutional Investor